Urea substituted imidazoquinolines
    6.
    发明授权
    Urea substituted imidazoquinolines 有权
    脲取代的咪唑并喹啉

    公开(公告)号:US07157453B2

    公开(公告)日:2007-01-02

    申请号:US11038434

    申请日:2005-01-20

    摘要: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain urea, thiourea, acylurea, or sulfonylurea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

    摘要翻译: 在1位含有尿素,硫脲,酰基脲或磺酰脲官能团的咪唑并喹啉和四氢咪唑并喹啉化合物可用作免疫应答调节剂。 本发明的化合物和组合物可以诱导各种细胞因子的生物合成,并且可用于治疗各种病症,包括病毒性疾病和肿瘤性疾病。